Hemodynamic and coronary effects of intravenous eletriptan, a 5HT1B/1D‐receptor agonist

[1]  L. Swan,et al.  The haemodynamic effect of the 5HT1 agonist BMS-180048: a class effect of triptans? , 1999, British journal of clinical pharmacology.

[2]  K. Hirata,et al.  5-HT1Dbeta receptor mediates the supersensitivity of isolated coronary artery to serotonin in variant angina. , 1998, Chest.

[3]  D. Birnie,et al.  The haemodynamic effects of subcutaneous sumatriptan, a 5HT1-receptor agonist. , 1997, British journal of clinical pharmacology.

[4]  D. Graham,et al.  Evidence for 5-HT1Dβ but not 5-HT1Dα receptor subtype expression in canine large coronary arteries and saphenous vein , 1996 .

[5]  P. Whorwell,et al.  Is chest pain after sumatriptan oesophageal in origin? , 1994, The Lancet.

[6]  W. Hillis,et al.  Effect of Subcutaneous Sumatriptan, a Selective 5HT1 Agonist, on the Systemic, Pulmonary, and Coronary Circulation , 1993, Circulation.

[7]  W. Inman,et al.  Cardiorespiratory distress after sumatriptan given by injection. , 1992, BMJ.

[8]  N. Curzen,et al.  Coronary vasospasm induced by subcutaneous sumatriptan. , 1992, BMJ.

[9]  A. A. Parsons,et al.  5‐HT1‐like receptors mediate 5‐hydroxytryptamine‐induced contraction of human isolated basilar artery , 1989, British journal of pharmacology.

[10]  A. Oxford,et al.  GR43175, a selective agonist for the 5‐HT1‐like receptor in dog isolated saphenous vein , 1988, British journal of pharmacology.

[11]  A. Doenicke,et al.  POSSIBLE BENEFIT OF GR43175, A NOVEL 5-HT1-LIKE RECEPTOR AGONIST, FOR THE ACUTE TREATMENT OF SEVERE MIGRAINE , 1988, The Lancet.

[12]  H. Mcintosh,et al.  The Incidence and Clinical Implications of Coronary Artery Spasm , 1975, Circulation.